This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Aug 26;351(9):856-7.

doi: 10.1056/NEJMp048184.

Predicting Progression--ZAP-70 in CLL

Terry J Hamblin¹

Affiliations

PMID: 15329421
DOI: 10.1056/NEJMp048184

Comment

Predicting Progression--ZAP-70 in CLL

Terry J Hamblin. N Engl J Med. 2004.

. 2004 Aug 26;351(9):856-7.

doi: 10.1056/NEJMp048184.

Author

Terry J Hamblin¹

Affiliation

¹ Department of Immunohaematology, University of Southampton, Southampton, United Kingdom.

PMID: 15329421
DOI: 10.1056/NEJMp048184

No abstract available

PubMed Disclaimer

Comment on

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, Neuberg DS, Flinn IW, Rai KR, Byrd JC, Kay NE, Greaves A, Weiss A, Kipps TJ. Rassenti LZ, et al. N Engl J Med. 2004 Aug 26;351(9):893-901. doi: 10.1056/NEJMoa040857. N Engl J Med. 2004. PMID: 15329427

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program